Journal of Craniofacial Surgery Study Proves Planatome Blades Reduce Tissue Damage and Improve Diabetic Wound Healing from Surgical Incisions
18 avr. 2024 12h09 HE
|
Planatome
A new study published in the Journal of Craniofacial Surgery highlights the superior performance of Planatome blades in surgical procedures.
Insulin delivery devices market Size Worth USD 27.37 Billion in 2032 | Emergen Research
18 janv. 2024 07h47 HE
|
Emergen Research
Vancouver, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The global insulin delivery devices market size was USD 13.37 billion in 2022 and is expected to register a revenue CAGR of 7.5% during the forecast...
Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)
25 avr. 2023 06h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect
05 avr. 2023 06h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
IMPORTANT CORPORATE DEVELOPMENTS - GLUCOSE HEALTH, INC. (OTC: GLUC)
03 nov. 2022 07h31 HE
|
Glucose Health, Inc.
Bentonville, AR, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) ("Company") confirms the following important corporate developments. Three outstanding candidates have...
Glucose Health, Inc. (OTC: GLUC) Quarterly Report – Q3 Fiscal 2022
24 oct. 2022 07h37 HE
|
Glucose Health, Inc.
BENTONVILLE, AR , Oct. 24, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial information from its third Quarterly Report of Fiscal...
Global Diabetic Retinopathy Market Is Expected to Reach $10.78 Billion by 2030: Says AMR
14 juin 2022 18h00 HE
|
Allied Market Research
Portland, OR, June 14, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Diabetic Retinopathy Market was estimated at $3.08 billion in 2020 and is...
Glucose Health, Inc. Corporate Update
24 mars 2022 07h35 HE
|
Glucose Health, Inc.
BENTONVILLE, AR, March 24, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC Pink: GLUC) ("Company") today provided the following corporate update, in response to requests from shareholders and...
Glucose Health, Inc. Corporate Update
17 mars 2022 15h00 HE
|
Glucose Health, Inc.
BENTONVILLE, AR, March 17, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC Pink: GLUC) ("Company") announced today, it has accepted the resignations of Hal Kravitz and John Fieldly from the...
Glucose Health, Inc. Fiscal 2021 Annual Report
10 févr. 2022 08h00 HE
|
Glucose Health, Inc.
BENTONVILLE, AR, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial metrics presented in its Fiscal 2021 Annual Report posted...